Centro de Pesquisa e Tecnologia Epidemiológica

  • Home
  • Centro de Pesquisa e Tecnologia Epidemiológica

Centro de Pesquisa e Tecnologia Epidemiológica Nossa missão: Atuar em parceria com instuições públicas e/ou privadas para o desenvolvimento de tecno

Atendimento imediato.Acesse o link abaixo ou escaneie o QR Code.
28/08/2020

Atendimento imediato.
Acesse o link abaixo ou escaneie o QR Code.

https://jamanetwork.com/journals/jama/fullarticle/2766036?guestAccessKey=fc00b759-a922-458c-914b-8b053609b71b&utm_source...
16/06/2020

https://jamanetwork.com/journals/jama/fullarticle/2766036?guestAccessKey=fc00b759-a922-458c-914b-8b053609b71b&utm_source=fbpage&utm_medium=social_jama&utm_term=3407710515&utm_campaign=article_alert&linkId=90460362&fbclid=IwAR0o5R1T3Iltp7KnlUbHayqg4fsZWAacNvUxI9MKeq3LWGZjkhnXgTlhvwo

This Viewpoint discusses considerations that might lead physicians to change their practice based on RCTs reporting non–statistically significant differences in primary outcomes, including trial methodology, totality of evidence, cost, invasiveness, and labor-intensiveness of the interventions...

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2https://rdcu.be/b4MWZ
11/06/2020

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
https://rdcu.be/b4MWZ

11/06/2020

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
https://rdcu.be/b4MWZ

Effective therapeutics to treat COVID-19 are urgently needed. While many investigational, approved, and repurposed drugs have been suggested, preclinical data from animal models can guide the search for effective treatments by ruling out treatments without in vivo efficacy. Remdesivir (GS-5734) is a...

Address


Website

Alerts

Be the first to know and let us send you an email when Centro de Pesquisa e Tecnologia Epidemiológica posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Want your business to be the top-listed Engineering Company?

Share